Cathie Wood Intellia Therapeutics, Inc. Transaction History
Ark Investment Management LLC
- $14.2 Billion
- Q3 2025
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 11,919,178 shares of NTLA stock, worth $104 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
11,919,178
Previous 13,017,876
8.44%
Holding current value
$104 Million
Previous $122 Million
68.58%
% of portfolio
1.45%
Previous 1.01%
Shares
36 transactions
Others Institutions Holding NTLA
# of Institutions
343Shares Held
103MCall Options Held
3.16MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA11MShares$96.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$83.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY6.02MShares$52.4 Million0.01% of portfolio
-
Contrarius Group Holdings LTD Hamilton, D05.89MShares$51.2 Million4.6% of portfolio
-
State Street Corp Boston, MA4.97MShares$43.2 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $661M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...